Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

NSCLC

  • Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of <sup>89</sup>Zr-Labeled Anti-PD-L1 Antibody Formats
    You have access
    Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
    Alizée Bouleau, Hervé Nozach, Steven Dubois, Dimitri Kereselidze, Céline Chevaleyre, Cheng-I Wang, Michael J. Evans, Vincent Lebon, Bernard Maillère and Charles Truillet
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1259-1265; DOI: https://doi.org/10.2967/jnumed.121.262967
  • 
    Study of <sup>89</sup>Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
    You have access
    Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
    Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
    Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
  • You have access
    Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
    Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli and Francesco Grossi
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 990-998; DOI: https://doi.org/10.2967/jnumed.119.233056
  • You have access
    What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
    Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball and Michael P. Mac Manus
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 328-334; DOI: https://doi.org/10.2967/jnumed.118.214148
  • You have access
    Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non–Small Cell Lung Cancer
    Zhaoguo Han, Yadi Xiao, Kai Wang, Ji Yan, Zunyu Xiao, Fang Fang, Zhongnan Jin, Yang Liu, Xilin Sun and Baozhong Shen
    Journal of Nuclear Medicine November 1, 2018, 59 (11) 1686-1691; DOI: https://doi.org/10.2967/jnumed.117.206730
  • You have access
    Parametric Method Performance for Dynamic 3′-Deoxy-3′-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Carcinoma Patients Before and During Therapy
    Gerbrand Maria Kramer, Virginie Frings, Dennis Heijtel, E.F. Smit, Otto S. Hoekstra and Ronald Boellaard; on behalf of the QuIC-ConCePT Consortium
    Journal of Nuclear Medicine June 1, 2017, 58 (6) 920-925; DOI: https://doi.org/10.2967/jnumed.116.178418
  • You have access
    Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients
    Gerbrand Maria Kramer, Virginie Frings, Nikie Hoetjes, Otto S. Hoekstra, Egbert F. Smit, Adrianus Johannes de Langen and Ronald Boellaard
    Journal of Nuclear Medicine September 1, 2016, 57 (9) 1343-1349; DOI: https://doi.org/10.2967/jnumed.115.170225
  • You have access
    18F-FDG PET/CT of Non–Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
    Irene A. Burger, Ruben Casanova, Seraina Steiger, Lars Husmann, Paul Stolzmann, Martin W. Huellner, Alessandra Curioni, Sven Hillinger, C. Ross Schmidtlein and Alex Soltermann
    Journal of Nuclear Medicine June 1, 2016, 57 (6) 849-854; DOI: https://doi.org/10.2967/jnumed.115.167684
  • You have access
    Evaluation of the Therapeutic and Diagnostic Effects of PEGylated Liposome–Embedded 188Re on Human Non–Small Cell Lung Cancer Using an Orthotopic Small-Animal Model
    Liang-Ting Lin, Chih-Hsien Chang, Hsiang-Lin Yu, Ren-Shyan Liu, Hsin-Ell Wang, Shu-Jun Chiu, Fu-Du Chen, Te-Wei Lee and Yi-Jang Lee
    Journal of Nuclear Medicine November 1, 2014, 55 (11) 1864-1870; DOI: https://doi.org/10.2967/jnumed.114.140418
  • You have access
    Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non–Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment
    Virginie Frings, Maqsood Yaqub, Lieke L. Hoyng, Sandeep S.V. Golla, Albert D. Windhorst, Robert C. Schuit, Adriaan A. Lammertsma, Otto S. Hoekstra, Egbert F. Smit, Ronald Boellaard and for the QuIC-ConCePT Consortium
    Journal of Nuclear Medicine September 1, 2014, 55 (9) 1417-1423; DOI: https://doi.org/10.2967/jnumed.114.140913

Pages

  • Next
  • 1
  • 2
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire